Angeles Wealth Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$449K Buy
7,149
+721
+11% +$57.7K 0.02% 253
2025
Q4
$613K Buy
6,428
+965
+18% +$94.6K 0.03% 180
2025
Q3
$533K Buy
5,463
+480
+10% +$49.7K 0.03% 180
2025
Q2
$535K Buy
4,983
+617
+14% +$62.4K 0.04% 177
2025
Q1
$440K Buy
4,366
+1,000
+30% +$101K 0.04% 153
2024
Q4
$301K Buy
3,366
+415
+14% +$36.5K 0.02% 210
2024
Q3
$247K Buy
+2,951
New +$233K 0.02% 234

Other funds holding BSX

Angeles Wealth Management's BSX Position: Q1 2026 in Review

Angeles Wealth Management increased its Boston Scientific (BSX) stake by 11% in Q1 2026, buying an estimated $57.7K and bringing the position to 7,149 shares worth $449K. The position accounts for 0.02% of the portfolio, ranked #253.

Angeles Wealth Management first reported a position in BSX in Q3 2024 and has held it in 7 quarters since. The position peaked at $613K in Q4 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Angeles Wealth Management held 7,149 shares of Boston Scientific worth $449K as of Q1 2026.
  • Angeles Wealth Management bought 721 Boston Scientific shares in Q1 2026, an estimated $57.7K.
  • Boston Scientific made up 0.02% of Angeles Wealth Management's portfolio in Q1 2026, its #253 holding.
  • Angeles Wealth Management first reported a position in Boston Scientific in Q3 2024 and has held it in 7 quarters since.
  • Angeles Wealth Management's Boston Scientific position peaked at $613K in Q4 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Angeles Wealth Management's 13F filing for Q1 2026, filed 6 May 2026.